Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.

BONORA, Stefano;GONZALEZ DE REQUENA, Daniel;D'AVOLIO, ANTONIO;CALCAGNO, Andrea;SICCARDI, MARCO;BAIETTO, LORENA;SIMIELE, MARCO;DI PERRI, Giovanni
2011

16
499
504
http://dx.doi.org/10.3851/IMP1802
Adenine; administration /&/ dosage/analogs /&/ derivatives/pharmacokinetics, Adult, Anti-HIV Agents; administration /&/ dosage/pharmacokinetics/therapeutic use, Deoxycytidine; administration /&/ dosage/analogs /&/ derivatives/pharmacokinetics, Drug Administration Schedule, Drug Therapy; Combination, HIV Seropositivity; drug therapy, HIV-1; drug effects, Humans, Male, Middle Aged, Oligopeptides; administration /&/ dosage/pharmacokinetics, Phosphonic Acids; administration /&/ dosage/pharmacokinetics, Pyridines; administration /&/ dosage/pharmacokinetics, Reverse Transcriptase Inhibitors; administration /&/ dosage/pharmacokinetics, Treatment Outcome
Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/95548
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact